Capivasertib China PK study

Trial Identifier:	D3614C00002
Sponsor:	AstraZeneca
NCTID::	NCT04742036
Start Date:	February 2021
Primary Completion Date:	July 2022
Study Completion Date:	July 2022
Condition:	Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
CN	Shanghai, CN, 200032

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.